These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9519421)

  • 61. Comparison of the Equil2 program and other methods for estimating the ion-activity product of urinary calcium oxalate: a new simplified method is proposed.
    Ogawa Y; Hatano T
    Int J Urol; 1996 Sep; 3(5):383-5. PubMed ID: 8886916
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Experimental technique simulating oxalocalcic renal stone generation.
    Söhnel O; Grases F; March JG
    Urol Res; 1993 Mar; 21(2):95-9. PubMed ID: 8503154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Insights into the pathophysiology and treatment of patients with calcium oxalate nephrolithiasis.
    Assimos DG
    J Urol; 1998 May; 159(5):1457-8. PubMed ID: 9554332
    [No Abstract]   [Full Text] [Related]  

  • 64. Measurement of nephrolithiasis urinary markers by capillary electrophoresis.
    García A; Muros M; Barbas C
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):287-95. PubMed ID: 11393716
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sodium urate accelerates precipitation of calcium oxalate in vitro.
    Coe FL; Lawton RL; Goldstein RB; Tembe V
    Proc Soc Exp Biol Med; 1975 Sep; 149(4):926-9. PubMed ID: 241080
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of inhibitors on the crystal growth of calcium oxalate.
    Minero C; Maggiorotti P; Barbeni M; Pelizzetti E; Tizzani A; Casetta G; Piana P; Giona C
    Contrib Nephrol; 1987; 58():65-72. PubMed ID: 3691149
    [No Abstract]   [Full Text] [Related]  

  • 67. Isolation and identification of some urinary inhibitors of calcium phosphate formation.
    Sutor DJ; Percival JM; Doonan S
    Clin Chim Acta; 1978 Oct; 89(2):273-8. PubMed ID: 213213
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Studies on calcium oxalate crystallization propensity in human urine. 1. Basal studies for measurement using an aggregometer].
    Yoshida T
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1693-700. PubMed ID: 3444160
    [No Abstract]   [Full Text] [Related]  

  • 69. Ionic strength dependence of formation constants-I Protonation constants of organic and inorganic acids.
    Daniele PG; Rigano C; Sammartano S
    Talanta; 1983 Feb; 30(2):81-7. PubMed ID: 18963323
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The synthesis and characterization of N-sulfo-2-amino tricarballylate: an analog of phosphocitrate and inhibitor of calcification.
    Brown MR; Sallis JD
    Anal Biochem; 1983 Jul; 132(1):115-23. PubMed ID: 6312833
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Calcification inhibitors in rat and human serum and plasma.
    Meyer JL; Fleisch H
    Biochim Biophys Acta; 1984 Jun; 799(2):115-21. PubMed ID: 6329313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of Acids on Selenite Inhibition of Salmonella typhimurium and Salmonella dublin.
    Huhtanen CN
    J Food Prot; 1978 Apr; 41(4):289-290. PubMed ID: 30795057
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Urinary crystals due to X-ray contrast medium.
    Sewell AC
    Nephron; 1996; 72(3):487-8. PubMed ID: 8852504
    [No Abstract]   [Full Text] [Related]  

  • 74. THE COMBINATION OF DIVALENT MANGANESE WITH CERTAIN PROTEINS, AMINO ACIDS, AND RELATED COMPOUNDS.
    Main RK; Schmidt CL
    J Gen Physiol; 1935 Sep; 19(1):127-47. PubMed ID: 19872906
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development of convenient crystallization inhibition assays for structure-activity relationship studies in the discovery of crystallization inhibitors.
    Yang J; Albanyan H; Wang Y; Yang Y; Sahota A; Hu L
    Med Chem Res; 2023 Jul; 32(7):1391-1399. PubMed ID: 37681210
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of the lysine on the calcium oxalate renal calculi.
    Atanassova SS
    Int Urol Nephrol; 2014 Mar; 46(3):593-7. PubMed ID: 24057683
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Urinary turbidity as a marker of crystallization: is spectrophotometric assessment useful?
    Kovacevic L; Lu H; Lakshmanan Y
    Int Urol Nephrol; 2013 Aug; 45(4):1009-15. PubMed ID: 23673777
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro.
    Barros ME; Schor N; Boim MA
    Urol Res; 2003 Feb; 30(6):374-9. PubMed ID: 12599017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of a turbidimetric assay to study the effect of urinary components on calcium oxalate precipitation.
    Saso L; Valentini G; Casini ML; Mattei E; Panzironi C; Silvestrini B
    Urol Int; 1998; 60(1):47-52. PubMed ID: 9519421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Development of an in vitro assay for the screening of substances capable of dissolving calcium oxalate crystals.
    Saso L; Valentini G; Leone MG; Grippa E; Silvestrini B
    Urol Int; 1998; 61(4):210-4. PubMed ID: 10364751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.